Financhill
Sell
25

EPOW Quote, Financials, Valuation and Earnings

Last price:
$0.77
Seasonality move :
-23.1%
Day range:
$0.75 - $0.82
52-week range:
$0.53 - $1.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.76x
Volume:
20.8K
Avg. volume:
27.1K
1-year change:
-32.33%
Market cap:
$20.5M
Revenue:
$45.1M
EPS (TTM):
--
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $17.9M $23.2M $7.4M $38.1M $45.1M
Revenue Growth (YoY) 32.4% 29.32% -68.04% 414.57% 18.16%
 
Cost of Revenues $2.1M $3M $3.9M $39.5M $57.5M
Gross Profit $15.8M $20.2M $3.5M -$1.4M -$12.4M
Gross Profit Margin 88.23% 87.14% 47.54% -3.54% -27.53%
 
R&D Expenses $795.5K $671.3K $2.2M $1.1M $1.2M
Selling, General & Admin $4.2M $4.8M $8.8M $13.8M $13.8M
Other Inc / (Exp) -$14.7K $71.8K -$1.7M -$6.1M -$3.4M
Operating Expenses $5M $5.5M $10.9M $14.8M $15M
Operating Income $10.8M $14.7M -$7.4M -$16.2M -$27.4M
 
Net Interest Expenses -- -- -- $27.1K $2.2M
EBT. Incl. Unusual Items $11M $15M -$9M -$22.3M -$32.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.6M $3.1M -$236.6K $809K -$230
Net Income to Company $9.4M $12M -$8.7M -$23.1M -$32.9M
 
Minority Interest in Earnings $365.6K $130.2K $311.1K $487.8K $8.7M
Net Income to Common Excl Extra Items $9.7M $12.1M -$8.4M -$22.6M -$24.2M
 
Basic EPS (Cont. Ops) $0.41 $0.54 -$0.36 -$0.98 -$1.08
Diluted EPS (Cont. Ops) $0.41 $0.54 -$0.36 -$0.98 -$1.08
Weighted Average Basic Share $23.5M $22.4M $23.6M $24.8M $25.6M
Weighted Average Diluted Share $23.5M $22.4M $23.6M $24.8M $25.6M
 
EBITDA $11.3M $16M -$6.3M -$13.8M -$22.9M
EBIT $10.8M $14.7M -$7.4M -$16.2M -$27.4M
 
Revenue (Reported) $17.9M $23.2M $7.4M $38.1M $45.1M
Operating Income (Reported) $10.8M $14.7M -$7.4M -$16.2M -$27.4M
Operating Income (Adjusted) $10.8M $14.7M -$7.4M -$16.2M -$27.4M
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $17.9M $23.2M $7.4M $38.1M $45.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) $17.9M $23.2M $7.4M $38.1M $45.1M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23 2024-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $9.4M $11M $13.9M $1.7M $1.4M
Short Term Investments -- -- $6M $3.3M --
Accounts Receivable, Net $5.3M $12.2M $6.9M $5.2M $8.9M
Inventory $3.3M $2.7M $3.1M $18.3M $15.8M
Prepaid Expenses $524.9K $1.4M $3.3M -- --
Other Current Assets -- -- -- $12.2M $6M
Total Current Assets $19.6M $28.3M $34.3M $44.6M $35.8M
 
Property Plant And Equipment $1.8M $3.5M $3.6M $41.5M $71.5M
Long-Term Investments $582.1K $3.1M $5.4M $3M $1.9M
Goodwill -- -- -- -- --
Other Intangibles $4.7M $4.3M $3.6M $14M $9.8M
Other Long-Term Assets -- -- $700.1K $14.4K $47.5K
Total Assets $27M $39.7M $58.7M $107M $120.5M
 
Accounts Payable $2.8M $33.7K $34.5K $12.3M $33.9M
Accrued Expenses $102.7K $25.9K $330.9K $639.8K $1.6M
Current Portion Of Long-Term Debt -- -- -- $3.7M $12.2M
Current Portion Of Capital Lease Obligations $263.8K $63.3K $99.6K -- $2.6M
Other Current Liabilities $369.3K $30.3K -- -- --
Total Current Liabilities $6.9M $5.6M $1.7M $26M $63.5M
 
Long-Term Debt -- -- -- $4.1M $6.5M
Capital Leases -- -- -- -- --
Total Liabilities $7M $5.6M $1.7M $33.7M $75.2M
 
Common Stock $1.7K $1.7K $2.5K $2.5K $2.6K
Other Common Equity Adj $1M $3.9M $4.6M $1.1M $488.9K
Common Equity $19.8M $34M $53.9M $28.7M $2.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $203K $111.2K $3.1M $44.7M $42.7M
Total Equity $20M $34.2M $57M $73.4M $45.3M
 
Total Liabilities and Equity $27M $39.7M $58.7M $107M $120.5M
Cash and Short Terms $9.4M $11M $19.9M $5M $1.4M
Total Debt -- -- -- $11.7M $22.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $9.4M $11M $13.9M $1.7M $1.4M
Short Term Investments -- -- $6M $3.3M --
Accounts Receivable, Net $5.3M $12.2M $6.9M $5.2M $8.9M
Inventory $3.3M $2.7M $3.1M $18.3M $15.8M
Prepaid Expenses $524.9K $1.4M $3.3M -- --
Other Current Assets -- -- -- $12.2M $6M
Total Current Assets $19.6M $28.3M $34.3M $44.6M $35.8M
 
Property Plant And Equipment $1.8M $3.5M $3.6M $41.5M $71.5M
Long-Term Investments $582.1K $3.1M $5.4M $3M $1.9M
Goodwill -- -- -- -- --
Other Intangibles $4.7M $4.3M $3.6M $14M $9.8M
Other Long-Term Assets -- -- $700.1K $14.4K $47.5K
Total Assets $27M $39.7M $58.7M $107M $120.5M
 
Accounts Payable $2.8M $33.7K $34.5K $12.3M $33.9M
Accrued Expenses $102.7K $25.9K $330.9K $639.8K $1.6M
Current Portion Of Long-Term Debt -- -- -- $3.7M $12.2M
Current Portion Of Capital Lease Obligations $263.8K $63.3K $99.6K -- $2.6M
Other Current Liabilities $369.3K $30.3K -- -- --
Total Current Liabilities $6.9M $5.6M $1.7M $26M $63.5M
 
Long-Term Debt -- -- -- $4.1M $6.5M
Capital Leases -- -- -- -- --
Total Liabilities $7M $5.6M $1.7M $33.7M $75.2M
 
Common Stock $1.7K $1.7K $2.5K $2.5K $2.6K
Other Common Equity Adj $1M $3.9M $4.6M $1.1M $488.9K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $203K $111.2K $3.1M $44.7M $42.7M
Total Equity $20M $34.2M $57M $73.4M $45.3M
 
Total Liabilities and Equity $27M $39.7M $58.7M $107M $120.5M
Cash and Short Terms $9.4M $11M $19.9M $5M $1.4M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $9.4M $12M -$8.7M -$23.1M -$32.9M
Depreciation & Amoritzation $496.2K $1.2M $1.1M $2.4M $4.5M
Stock-Based Compensation -- -- -- $2.7M $2.1M
Change in Accounts Receivable -$6.7M -$8.5M $1.8M -$3M -$4.3M
Change in Inventories -$823.8K $667.8K -$331.5K -$18.7M -$5.1M
Cash From Operations $1.2M $7.1M -$5.2M -$9.6M -$7.3M
 
Capital Expenditures $3.5M $4.5M $8.3M $44.1M $7.2M
Cash Acquisitions -- -- -$9.3K -- --
Cash From Investing -$3.5M -$6.4M -$22.1M -$45.6M -$7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $9.6M $22.1M
Long-Term Debt Repaid -- -- -- -$887.8K -$8.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $238.1K $120K $3.3M $37M $148.1K
Cash From Financing $238.1K $120K $30.8M $45.8M $13.7M
 
Beginning Cash (CF) $11.7M $9.4M $11M $14.6M $4.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.1M $820.6K $3.5M -$9.4M -$606.8K
Ending Cash (CF) $9.4M $11M $14.6M $4.3M $3.6M
 
Levered Free Cash Flow -$2.3M $2.6M -$13.6M -$53.7M -$14.4M
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.2M $7.1M -$5.2M -$9.6M -$7.3M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23 2024-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock